Welcome to the IAM Patent 1000 2016 – The World’s Leading Patent Professionals, the fifth edition of Intellectual Asset Management’s market-leading guide that identifies and profiles leading private practice patent professionals and firms in the world’s key jurisdictions.Read more
The IAM Patent 1000 is unique in being a one-stop resource that focuses exclusively on naming best-in-class patent prosecution, licensing and litigation practitioners on a global basis, as well as expert witnesses in the United States. For five months, a dedicated research team working out of our offices in London and Hong Kong conducted detailed interviews with thousands of private practice lawyers and attorneys based in dozens of countries, as well as the users of their services, in order to identify the practitioners and practices that are considered to excel at providing patent-related legal services. In the United States, we also asked interviewees to name the expert witnesses they turn to when they need world-class input on both damages and technical issues. The firms and individuals listed on the following pages are the results of that research.
All those listed in the IAM Patent 1000 are included because we received substantial positive feedback about them from multiple sources. We do not claim that we have managed to find every top name in every jurisdiction covered; but we are confident that we have included the vast majority, and that everybody who is listed fully deserves the recognition. For a detailed methodology that explains the research process, as well as how the research team decides who should finally be listed, please click here.
In addition to the listings and editorial, there is further biographical information on some of the individuals featured at the end of each country section, and on some of the selected firms at the end of each regional chapter. All those selected for inclusion in the IAM Patent 1000 are offered the opportunity to publish this information for a fee – some opt to do so, while others do not. Either way, it has no effect on listing or ranking decisions. The research was conducted entirely independently of any commercial considerations.
Search IAM Patent 1000
De Vries & Metman (DVME) delivers patent, trademark and design protection services via its three offices in the Netherlands in all fields of technology. With its main office in Amsterdam, DVME is widely recognised as a high-quality patent attorney firm. Its client portfolio ranges from global operating multinationals to high-tech start-ups, universities and research institutions. DVME represents clients before the Dutch and European Patent Office (EPO), as well as before the Belgium Patent Office. DVME has a technically qualified attorney at law and many of its attorneys have industry experience.In addition to its patent prosecution work, DVME has strong expertise in handling ...
Inga-Lill Andersson is a senior European patent attorney specialising in the fields of chemistry and biotechnology, with a particular focus on protein chemistry, pharmaceutical chemistry, biochemistry and implant technology. In her daily work, Ms Andersson engages in all types of patent-related issue encompassing infringement and validity, such as patentability evaluations, drafting and prosecution of patent applications, due diligence investigations and freedom-to-operate analyses. Ms Andersson has comprehensive experience of oppositions and appeals before the European Patent Office (EPO). She also completed an internship at a Technical Board of Appeal at the EPO’s ...
High-technology disputes dominated the headlines in Israel last year. With pharmaceutical litigation in decline, some had feared for the prospects of the nation’s contentious IP practices. These concerns were allayed, however, by a significant rise in ownership clashes among innovative start-ups in the communications protocols space and the growing threat of non-practising entities making incursions on the market. Other highlights included a Supreme Court ruling that inventors working for institutions have no rights to their inventions. The ramifications remain to be seen; but whatever the outcome, it looks set to keep the country’s pluralistic firms busy for some time.
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email